487 related articles for article (PubMed ID: 24961530)
1. Myelin recovery in multiple sclerosis: the challenge of remyelination.
Podbielska M; Banik NL; Kurowska E; Hogan EL
Brain Sci; 2013 Aug; 3(3):1282-324. PubMed ID: 24961530
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of glia repair and remyelination in antibody-mediated demyelination models of multiple sclerosis and neuromyelitis optica.
Liu Y; Given KS; Owens GP; Macklin WB; Bennett JL
Glia; 2018 Dec; 66(12):2575-2588. PubMed ID: 30240044
[TBL] [Abstract][Full Text] [Related]
3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
4. Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.
Melchor GS; Khan T; Reger JF; Huang JK
ACS Pharmacol Transl Sci; 2019 Dec; 2(6):372-386. PubMed ID: 32259071
[TBL] [Abstract][Full Text] [Related]
5. Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
Baxi EG; DeBruin J; Tosi DM; Grishkan IV; Smith MD; Kirby LA; Strasburger HJ; Fairchild AN; Calabresi PA; Gocke AR
J Neurosci; 2015 Jun; 35(22):8626-39. PubMed ID: 26041928
[TBL] [Abstract][Full Text] [Related]
6. Immune promotion of central nervous system remyelination.
Rodriguez M; Miller DJ
Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
[TBL] [Abstract][Full Text] [Related]
7. Targeting oligodendrocyte protection and remyelination in multiple sclerosis.
Zhang J; Kramer EG; Mahase S; Dutta DJ; Bonnamain V; Argaw AT; John GR
Mt Sinai J Med; 2011; 78(2):244-57. PubMed ID: 21425268
[TBL] [Abstract][Full Text] [Related]
8. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
9. Donepezil, a drug for Alzheimer's disease, promotes oligodendrocyte generation and remyelination.
Cui X; Guo YE; Fang JH; Shi CJ; Suo N; Zhang R; Xie X
Acta Pharmacol Sin; 2019 Nov; 40(11):1386-1393. PubMed ID: 30918344
[TBL] [Abstract][Full Text] [Related]
10. S100B Impairs Oligodendrogenesis and Myelin Repair Following Demyelination Through RAGE Engagement.
Santos G; Barateiro A; Brites D; Fernandes A
Front Cell Neurosci; 2020; 14():279. PubMed ID: 33100970
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.
Murray PD; McGavern DB; Sathornsumetee S; Rodriguez M
Brain; 2001 Jul; 124(Pt 7):1403-16. PubMed ID: 11408335
[TBL] [Abstract][Full Text] [Related]
12. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
13. Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Gaesser JM; Fyffe-Maricich SL
Exp Neurol; 2016 Sep; 283(Pt B):501-11. PubMed ID: 26957369
[TBL] [Abstract][Full Text] [Related]
14. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
15. Remyelination in multiple sclerosis from the miRNA perspective.
Maciak K; Dziedzic A; Saluk J
Front Mol Neurosci; 2023; 16():1199313. PubMed ID: 37333618
[TBL] [Abstract][Full Text] [Related]
16. IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Psachoulia K; Chamberlain KA; Heo D; Davis SE; Paskus JD; Nanescu SE; Dupree JL; Wynn TA; Huang JK
Brain; 2016 Dec; 139(Pt 12):3121-3136. PubMed ID: 27797811
[TBL] [Abstract][Full Text] [Related]
17. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
Zhang S; Zhu X; Gui X; Croteau C; Song L; Xu J; Wang A; Bannerman P; Guo F
J Neurosci; 2018 Feb; 38(7):1802-1820. PubMed ID: 29335358
[TBL] [Abstract][Full Text] [Related]
18. The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.
Blades F; Aprico A; Akkermann R; Ellis S; Binder MD; Kilpatrick TJ
Glia; 2018 Oct; 66(10):2209-2220. PubMed ID: 30208252
[TBL] [Abstract][Full Text] [Related]
19. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.
Kataria H; Alizadeh A; Shahriary GM; Saboktakin Rizi S; Henrie R; Santhosh KT; Thliveris JA; Karimi-Abdolrezaee S
Glia; 2018 Mar; 66(3):538-561. PubMed ID: 29148104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
